Large population-based health administrative databases, clinical registries, and data
linkage systems are a rapidly expanding resource for health research. Ophthalmic research …

Glaucoma and ocular hypertension are highly prevalent conditions in individuals over the
age of 40 and are commonly seen together in patients with cardiovascular disease. Many of …

Introduction Fixed-combination intraocular pressure (IOP)—lowering medications simplify
treatment regimens for patients requiring 2 ocular hypotensive agents to maintain sufficiently …

Purpose: To identify the extent of use of medicines recommended to be used with caution in
glaucoma patients with specified comorbidities and to determine evidence of associated …

Purpose To analyze patterns of use of adjunctive therapies among new initiators of topical
prostaglandin analogs (PGAs) in a managed care population. Methods The study cohort …

PURPOSE: To summarize observational studies that focus on the use of glaucoma
medications and to identify gaps in knowledge to guide future investigation. DESIGN …

Introduction Few studies have examined outcomes and potential complications among
glaucoma patients who are prescribed topical beta-blockers. This study examined resource …

Purpose: To determine the frequency and economic impact of changing initial glaucoma
therapy for patients with newly diagnosed open-angle glaucoma (OAG) or ocular …

Objective To determine if topical beta-blocker use is associated with increased risks of
cardiovascular and respiratory diseases in patients with glaucoma. Setting A retrospective …

Objectives: Topical β-blockers are contraindicated in obstructive pulmonary diseases
(OPDs). In this study we aimed to evaluate through central or local electronic medical …